Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

HealthLynked (HLYK) FCF Margin (2016 - 2025)

Historic FCF Margin for HealthLynked (HLYK) over the last 10 years, with Q3 2025 value amounting to 114.35%.

  • HealthLynked's FCF Margin rose 613700.0% to 114.35% in Q3 2025 from the same period last year, while for Sep 2025 it was 85.84%, marking a year-over-year increase of 329700.0%. This contributed to the annual value of 116.23% for FY2024, which is 437700.0% down from last year.
  • HealthLynked's FCF Margin amounted to 114.35% in Q3 2025, which was up 613700.0% from 70.49% recorded in Q2 2025.
  • HealthLynked's 5-year FCF Margin high stood at 230.02% for Q4 2021, and its period low was 175.72% during Q3 2024.
  • In the last 5 years, HealthLynked's FCF Margin had a median value of 75.25% in 2022 and averaged 64.88%.
  • As far as peak fluctuations go, HealthLynked's FCF Margin surged by 2948800bps in 2021, and later plummeted by -2727100bps in 2022.
  • Quarter analysis of 5 years shows HealthLynked's FCF Margin stood at 230.02% in 2021, then plummeted by -119bps to 42.7% in 2022, then tumbled by -200bps to 128.04% in 2023, then increased by 6bps to 120.14% in 2024, then rose by 5bps to 114.35% in 2025.
  • Its FCF Margin stands at 114.35% for Q3 2025, versus 70.49% for Q2 2025 and 55.87% for Q1 2025.